Therapeutic drugs

Application model of ASO and RNAi therapy in metabolic diseases

What are Oligonucleotide Therapies?

Oligonucleotides are short synthetic DNA or RNA polymers, which modulate gene expression through Watson-Crick base pairing with targeted nucleic acids. Oligonucleotides regulate gene expression through a series of processes, including […]

New Drug Report 2020 -10

New Drug Report 2020 -10

The Janus kinase (JAK1) inhibitor Figotinib (Jyseleca; Gilead) was approved in Japan and the European Union in September 2020. The approved indication in Japan is the treatment of patients with […]